Cardiol Therapeutics Inc Class A (CRDL : TSX)
Common Stock
$1.67
CAD
-0.07 (-4.02%)
Last updated: 2026-07-24
Get CRDL alerts:
CRDL
Cardiol Therapeutics Inc Class A
WealthAwesomePerformance
1 Day
-4.02%
1 Week
-1.18%
1 Month
+12.08%
YTD
+22.79%
Key Statistics
Market Cap
$192.50M
52W High
$2.33
52W Low
$1.23
P/E Ratio
-
50 Day MA
$1.61
200 Day MA
$1.55
Beta
0.51
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/24/2026 | $1.74 | $1.74 | $1.64 | $1.67 | $1.67 | 91,829 |
| 7/23/2026 | $1.79 | $1.85 | $1.72 | $1.74 | $1.74 | 104,939 |
| 7/22/2026 | $1.79 | $1.82 | $1.74 | $1.82 | $1.82 | 110,138 |
| 7/21/2026 | $1.76 | $1.82 | $1.73 | $1.77 | $1.77 | 94,737 |
| 7/20/2026 | $1.76 | $1.81 | $1.65 | $1.75 | $1.75 | 136,772 |
| 7/17/2026 | $1.74 | $1.74 | $1.65 | $1.69 | $1.69 | 112,633 |
| 7/16/2026 | $1.57 | $1.81 | $1.51 | $1.74 | $1.74 | 177,653 |
| 7/15/2026 | $1.65 | $1.65 | $1.53 | $1.58 | $1.58 | 68,737 |
| 7/14/2026 | $1.50 | $1.69 | $1.50 | $1.63 | $1.63 | 185,764 |
| 7/13/2026 | $1.44 | $1.52 | $1.44 | $1.50 | $1.50 | 87,301 |
Analyst Price Targets
Based on analyst covering CRDL
Wall Street analysts forecast CRDL stock price to rise 259.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+259.3% Upside
Current Price
C$1.67
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRDL's historical volatility
30-Day Vol
51.3%
Annualized
90-Day Vol
60.3%
Annualized
Trend (90d)
-29.1%
Annualized drift
90d Mean
C$1.50
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.61 | C$1.35 – C$1.93 |
| 60 trading days | C$1.56 | C$1.21 – C$2.00 |
| 90 trading days | C$1.50 | C$1.11 – C$2.04 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Cardiol Therapeutics Inc Class A
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-35.57M
- Profit Margin
- 0.00%
- ROE (TTM)
- -173.96%
- EPS (Diluted)
- -0.39
- Book Value
- 0.22
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About CRDL
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| FOOD | Goodfood Market Corp | $0.04 | +16.67% |
| BRE | Bridgemarq Real Estate Services Inc | $5.18 | +14.10% |
| CNT | Century Global Commodities Corp | $0.05 | +11.11% |
| GCU | Gunnison Copper Corp | $0.36 | +10.61% |
| QEC | Questerre Energy Corporation | $0.28 | +10.00% |
| DBO | D-Box Technologies Inc. | $1.19 | +9.17% |
| NVO | Novo Resources Corp | $0.06 | +9.09% |
| AEM-CV | AGNICO EAGLE MINES LIMITED CVR | $0.60 | +9.09% |
Latest coverage of CRDL.TO
Most recent articles mentioning this ticker